Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis

Journal of Leukocyte Biology

Volumn 97, Issue 1, 2015, Pages 161-169

  Barnes, Mark A ^a,c   McMullen, Megan R ^c   Roychowdhury, Sanjoy ^c   Madhun, Nabil Z ^c   Niese, Kathryn ^c   Olman, Mitchell A ^c   Stavitsky, Abram B ^a,c   Bucala, Richard ^b   Nagy, Laura E ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Carbon tetrachloride; MIF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; COLLAGENASE 3; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; ISOMERASE; MIF PROTEIN, MOUSE; MMP13 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; FEMALE; IMMUNE RESPONSE; INVESTIGATIVE PROCEDURES; LIVER FIBROSIS; LONG TERM EXPOSURE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR ASSOCIATED MACROPHAGE; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER CIRRHOSIS; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR;

MUS;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; CICATRIX; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; LIVER CIRRHOSIS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84925285089     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0614-280R     Document Type: Article

References (47)

1. Bataller, R., Brenner, D. A. (2005) Liver fibrosis. J. Clin. Invest. 115, 209-218.
2. Ikeda, K., Wakahara, T., Wang, Y. Q., Kadoya, H., Kawada, N., Kaneda. K. (1999) In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Heftatology 29, 1760-1767.
3. Schwa be, R. F., Bataller, R., Brenner, D. A. (2003) Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G949-G958.
4. Wake, K. (1971) "Stemzellen" in the liver: pcrisinusoidal cells with special reference to storage of vitamin A. Am. J. Anal. 132, 429-462.
5. Puche, J. E., Saiman, Y., Friedman, S. I. (2013) Hepatic stellate cells and liver fibrosis. Compr. Physiol. 3, 1473-1492.
6. Inagaki, Y., Okazaki, I. (2007) Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56, 284-292.
7. Borkham-Kamphorst, E., Stoll, D., Gressner, A. M., Weiskirchen, R. (2004) Antisense strategy against PDGF B-chain prows effective in preventing experimental liver fibrogenesis. Biochem. Biophys. Res. Commun. 321, 413-423.
8. Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., Gores, G. J. (2003) Apoptotic body enguifment by a human stellate cell line is profibrogenic. Lab. Invest. 83, 655-663.
9. Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., Weiskirchen, R. (2013) Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair 6, 19.
10. Lee, U. E., Friedman, S. L. (2011) Mechanisms of hepatic fibrogenesis. Best Pract. Res. Clin. Gastroenterol. 25, 195-206.
11. Caxini, A., Ceni, E., Salzano, R, Biondi, P., Parola, M., Galli, A., Foschi, M., Caligiuri, A., Pinzani, M., Surrenti, C. (1997) Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 25, 361-367.
12. Wynn, T. A., Barron, L. (2010) Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245-257.
13. Gao, B., Radaeva, S. (2013) Natural killer and natural killer T cells in liver fibrosis. Biochim. Biophys. Acta 1832, 1061-1069.
14. Gao, B., Waisman, A. (2012) Thl7 cells regulate liver fibrosis by targeting multiple cell types: many birds with one stone. Gastroenterology 143, 536-539.
15. Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., Gao, B. (2006) Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130, 435-452.
16. Park, O., Jeong, W. I., Wang, L., Wang, H., Lian, Z. X., Gershwin, M. E., Gao, B. (2009) Diverse roles of invariant natural killer T cells in liver in jury and fibrosis induced by carbon tetrachloride. Hepatobgt 49, 1683-1694.
17. Fallowfield. J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Bcnyon, R. C., Duffield, J. S., Iredale. J. P. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178, 5288-5295.
18. Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott. R. L., Ali, A., Hartland, S. N., Snowdon, V. K, Cappon, A., Gordon-W'alker, T. T., Williams, M. J., Dunbar, D. R., Manning, J. R., van Rooijen, N., Fallowfield. J. A., Forbes, S. J., Iredale. J. P. (2012) Differential Ly-6G expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sri. USA 109, E3186-E3195.
19. Baeck, G, Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassier, N., Eulberg, D., Luedde, T., Trautwein. C, Tacke. F. (2014) Pharmacological inhibition of the chemokine GC modf chemokine ligand 2 (monocyte chemoattraciant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice. Hepatology 59, 1060-1072.
20. Akbar, S. M. F., Abe, M., Murakami, H., Tanimoto, K., Kumagi, T., Yamashita, Y., Michitaka, K., Horiike, N., Onji, M. (2001) Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett. 171, 125-132.
21. Kumagi, T., Akbar, F., Horiike, N., Onji, M. (2001) Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin. Biochem. 34, 189-193.
22. Akyildiz, M., Gunsar, F., Nan, D., Sahin, O., Mimal, F., Akay, S., Ersoz, G., Karasu, Z., liter, T., Batur, Y., Berdeli, A., Akarca, Ú. (2010) Macrophage migration inhibitory factor expression and MIF gene-173 G/C polymorphism in nonalcoholic fatty liver disease. Em. J. Gastroenterol Hepatol. 22, 192-198.
23. Yuan, Q., Wang, M., W'ang, M., Zhang, Z., Zhang, W. (2012) Macrophage migration inhibitory factor gene-173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis. MoL Biol Rep. 39, 3109-3115.
24. Bames, M. A. McMullen, M. R., Roychowdhury, S., Pisano, S. G., Liu, X., Stavitsky, A. B., Bucala, R., Nagy, L. E. (2013) Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitls, and steatosis. Hepatology 57, 1980-1991.
25. Heinrichs, D., Knaucl, M., Offermanns, C., Berres, M. L., Nellen, A., Leng, L., Schmiu, P. Bucala. R., Trautwein, C, Weber, C., Bemhagen. J., Wasmuth, H. E. (2011) Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc. Natl. Acad. Sri. USA 108, 17444-17449.
26. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, G, David, J. R (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346.
27. Sisson, T. H., Mendez, M., Choi, K., Subbotina, N., Courey, A., Cunningham, A., Dave, A., Engelhardt. J. K., Liu, X., White, E. S., Thannickal, V. J., Moore, B. B., Christensen, P. J., Simon, R. D. (2010) Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 181, 254-263.
28. Pritchard, M'. T., McMullen, M. R., Stavitsky, A. B. Cohen, J. I., Lin, F., Medof, M. F. Nagy. L. E. (2007) Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132, 1117-1126.
29. Gogly, B., Groult, N. Hornebeck, W., Godeau, G., Pellat, B. (1998) Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal. Biochem. 255, 211-216.
30. Pritchard, M. T., Nagy, L E. (2010) Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-dcficicnt mice. Am. J. Pathol. 176, 2743-2752.
31. Roychowdhury, S., Chiang, D. J., Mandal, P., McMullen. M. R. Liu, X., Cohen, J. I., Pollard, J., Feldstein, A. E., Nagy. L. F. (2012) Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CC14-induced fibrosis but not steatosis or inflammation. Alcohol. Clin. Exp. Res. 36, 1139-1147.
32. Pritchard, M. T., Cohen, J. I., Roychowdhury, S., Pratt, B. T. Nagy, I. F. (2010) Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J. Hefxitol. 53, 655-662.
33. Wong. F. W., Chan. W. Y. Lee, S. S. (1998) Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack YP2F. 1 expression. Toxicol. Appl. Pharmacol. 153, 109-118.
34. Ramachandran, P., Iredale. J. P. (2012) Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM 105, 813-817.
35. David, J. R. (1966) Delayed hypersensitivity in vitro: its mediation by well-free substances formed by lymphoid cell-antigen interaction, Proc. Natl. Acad. Sri. USA 56, 72-77.
36. Assis, D. N., Leng. L., Du, X., Zhang, C. K., Grieb, G., Merk, M., Garcia, A. B., McCrann, C., Chapiro. J. Meinhardt, A. Mizue. V. Nikolic-Paterson, D. J., Bernhagen, J., Kaplan. M. M., Zhao, H., Boyer, J. I., Bucala, R. (2014) The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology 59, 580-591.
37. Hardman. M. J. Waite. A. Zeef, L., Burow, M. Nakayama. T. Ashcroft, G. S. (2005) Macrophage migration inhibitory factor: a central legulator of wound healing. Am. J. Pathol 167, 1561-1574.
38. Fingerle-Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, I. J., Mitchell, R., Huss, R., Moll, U., Müller. W. Bucala, R. (2003) The p53-dcpcndent effects of macrophage migration inhibitory fatctor revealed by gene targeting. Pm. Natl. Arad. Sri. USA 100, 9354-9359.
39. Gilliver, S. C., Ruckshanthi, J. P., Hardman, M. J., Nakayama, I., Ashcroft. G. S. (2008) Sex dimorphism in wound healing: the roles ol sex steroids and macrophage migration inhibitory factor. Endocrinology 149, 5747-5757.
40. Calandra, T., Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800.
41. Hori, Y, Sato, S., Yamate. J., Kurasaki, M., Nishihira, J., Hosokawa, I., Fujita, H., Saito, T. (2003) Iminunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetantide. Eur. J. Histochem. 47, 317-324.
42. Hemmann, S., Graf. J., Roderfeld, M., Roeb, K. (2007) Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J. Ileftalol. 46, 955-975.
43. Wang. D. R., Sato, M., Li, L. N. Miura, M., Kojinia, N. Senoo, H. (2003) Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells. Oil Struct. Fund. 28, 505-513.
44. Madala. S. K., Pesce. J. T., Ramalingam. T. R. Wilson. M. S., Minnicozi, S., Cheever, A. W., Thompson, R. W., Mentink-Kane, M. M., Wynn, T. A. (2009) Matrix metalloproteiiui. se 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates Il/-13κlependent fibrosis. J. Immunol. 184, 3955-3963.
45. Aoyama, T., Inokuchi, S., Brenner, D. A., Seki, E. (2010) CX3C1. 1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52, 1390-1400.
46. Seki, E., De Minicis, S., Gwak, G. Y., Kluwe, J., Inokuchi, S., Bursill. C. A., Llovet, J. M., Brenner. D. A., Schwabe, R. F. (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J. Clin. Invest. 119, 1858-1870.
47. Yang, L., Kwon, J., Popov, Y., Gajdos, G. B. Ordog, T., Brekken, R. A., Mukhopadhyay, D., Schuppan, D., Bi, Y., Simonetto. D. Shah, V. H. (2014) V'ascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146, 1339-1350. e 1.